Source: International Congress 2017 – Monitoring asthma control
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Heffler (Torino, To, Italy). Point-of-care blood eosinophils count in a severe asthma clinic setting. 4758

Member's Comments

No comment yet.

Related content which might interest you: Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA) Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020 The usefulness of blood eosinophil count and FeNO to predict sputum eosinophilia in the diagnosis of severe eosinophilic asthma Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019 Impact on steroid dosing after introducing sputum eosinophils count into a severe asthma clinic Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 The blood eosinophil count as a biomarker in COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015 Blood eosinophil count and exacerbation risk in patients with COPD Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017 Year: 2017 Clinical significance of blood neutrophil differential count in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 FENO and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Mepolizumab does not alter blood basophil count in severe asthma Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 Association between blood eosinophil count and risk of exacerbations in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Systemic inflammation, blood eosinophils count and lung function in COPD patients Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Peripheral eosinophil count as a biomarker for the management of COPD: not there yet Source: Eur Respir J, 50 (5) 1702165; 10.1183/13993003.02165-2017 Year: 2017 The reproducibility of COPD blood eosinophil counts Source: Eur Respir J, 52 (1) 1800427; 10.1183/13993003.00427-2018 Year: 2018 Reproducibility of COPD blood eosinophil counts Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Blood eosinophil count as a predictor of treatment response in adult patients with chronic cough Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020 Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD Source: Eur Respir J, 51 (5) 1800120; 10.1183/13993003.00120-2018 Year: 2018 Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Stability of blood eosinophils over time in patients with asthma Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Serial blood eosinophils and clinical characteristics in COPD patients without a history of asthma or atopy Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 Association between blood eosinophil counts and risk of rehospitalization in patients with asthma Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017 Blood eosinophil count predicts treatment failure and hospital readmission for COPD Source: ERJ Open Res, 6 (4) 00188-2020; 10.1183/23120541.00188-2020 Year: 2020